Evidence map›Paper›PMID 39198580›Full record

ReviewNeuropsychopharmacology : official publication of the American College of Neuropsychopharmacology2024

What can neuroimaging of neuromodulation reveal about the basis of circuit therapies for psychiatry?

Satoka Fujimoto, Atsushi Fujimoto, Catherine Elorette, Ki Sueng Choi, Helen Mayberg, Brian Russ, Peter Rudebeck

Erratum issuedAbstract readReview
In one paragraph

Review in Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Review
  6. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors.

Satoka FujimotoNash Family Department of Neuroscience and Friedman Brain Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.ORCID 0000-0003-2374-3002
Atsushi FujimotoNash Family Department of Neuroscience and Friedman Brain Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.ORCID 0000-0002-1621-2003
Catherine EloretteNash Family Department of Neuroscience and Friedman Brain Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.ORCID 0000-0001-5735-4369
Ki Sueng ChoiNash Family Center for Advanced Circuit Therapeutics, Icahn School of Medicine at Mount Sinai, New York, NY, USA.ORCID 0000-0002-6446-0677
Helen MaybergNash Family Center for Advanced Circuit Therapeutics, Icahn School of Medicine at Mount Sinai, New York, NY, USA.ORCID 0000-0002-1672-2716
Brian RussNash Family Department of Neuroscience and Friedman Brain Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA. brian.russ@nki.rfmh.org.
Peter RudebeckNash Family Department of Neuroscience and Friedman Brain Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA. peter.rudebeck@mssm.edu.ORCID 0000-0002-1411-7555

Funding

Electrophysiological Biomarkers to Optimize DBS for DepressionUH3NS103550 · NINDS · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI MAYBERG, HELEN S, RIVA-POSSE, PATRICIO · 2017 to 2023
$7.7M
Connectomic Deep Brain Stimulation for Obsessive Compulsive DisorderR01MH123542 · NIMH · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI CHOI, KI SUENG, FIGEE, MARTIJN · 2021 to 2025
$3.7M
Establishing the anatomical and functional mechanisms of white matter deep brain stimulationRF1MH132789 · NIMH · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI MAYBERG, HELEN S, RUDEBECK, PETER · 2025 to 2025
$2.4M
Establishing the anatomical and functional mechanisms of white matter deep brain stimulationR01MH132789 · NIMH · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI MAYBERG, HELEN S, RUDEBECK, PETER · 2023 to 2024
$1.6M
Brain and Behavior Research Foundation (Brain & Behavior Research Foundation) 28979Hope for Depression Research Foundation (Depression Research Foundation) NANIMH NIH HHS R01 MH123542NIMH NIH HHS R01 MH132789NIMH NIH HHS RF1 MH132789NINDS NIH HHS UH3 NS103550U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (NIMH) R01MH123542U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (NIMH) R01MH132789U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke (NINDS) UH3NS103550
6 · The paper itself

Abstract

Neuromodulation is increasingly becoming a therapeutic option for treatment resistant psychiatric disorders. These non-invasive and invasive therapies are still being refined but are clinically effective and, in some cases, provide sustained symptom reduction. Neuromodulation relies on changing activity within a specific brain region or circuit, but the precise mechanisms of action of these therapies, is unclear. Here we review work in both humans and animals that has provided insight into how therapies such as deep brain and transcranial magnetic stimulation alter neural activity across the brain. We focus on studies that have combined neuromodulation with neuroimaging such as PET and MRI as these measures provide detailed information about the distributed networks that are modulated and thus insight into both the mechanisms of action of neuromodulation but also potentially the basis of psychiatric disorders. Further we highlight work in nonhuman primates that has revealed how neuromodulation changes neural activity at different scales from single neuron activity to functional connectivity, providing key insight into how neuromodulation influences the brain. Ultimately, these studies highlight the value of combining neuromodulation with neuroimaging to reveal the mechanisms through which these treatments influence the brain, knowledge vital for refining targeted neuromodulation therapies for psychiatric disorders.

Indexed as

BrainMental DisordersNeuroimagingAnimalsDeep Brain StimulationHumansNeurotransmitter AgentsTranscranial Magnetic StimulationNeurotransmitter Agents

Identifiers

PMID39198580
PMCPMC11526173

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.